250
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence

ORCID Icon, ORCID Icon, , , , & show all
Pages 663-678 | Received 01 Feb 2024, Accepted 15 Apr 2024, Published online: 19 Apr 2024

References

  • Albuquerque RG, Rocha MA, Bagatin E, et al. Could adult female acne be associated with modern life? Arch Dermatol Res. 2014;306:683–688. doi:10.1007/s00403-014-1482-6
  • Ayer J, Burrows N. Acne: more than skin deep. Postgrad Med J. 2006;82:500–506. doi:10.1136/pgmj.2006.045377
  • Tuchayi SM, Makrantonaki E, Ganceviciene R, et al. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. doi:10.1038/nrdp.2015.29
  • Kutlu Ö, Karadağ AS, Wollina U. Adult acne versus adolescent acne: a narrative review with a focus on epidemiology to treatment. An Bras Dermatol. 2023;98:75–83. doi:10.1016/j.abd.2022.01.006
  • Pease E. Suspect endocrine disorder in cases of severe adult acne. JAMA. 1981;246:1391–1392.
  • Preneau S, Dreno B. Female acne - a different subtype of teenager acne? J Eur Acad Dermatol Venereol. 2012;26:277–282. doi:10.1111/j.1468-3083.2011.04214.x
  • Bagatin E, Freitas THP, Rivitti-Machado MBM, et al. Adult female acne: a guide to clinical practice. An Bras Dermatol. 2019;94:62–75. doi:10.1590/abd1806-4841.20198203
  • Rocha MA, Bagatin E. Skin barrier and microbiome in acne. Arch Dermatol Res. 2018;310:181–185. doi:10.1007/s00403-017-1795-3
  • Castillo DE, Nanda S, Keri JE. Propionibacterium (Cutibacterium) acnes bacteriophage therapy in acne: current evidence and future perspectives. Dermatol Ther. 2019;9:19–31. doi:10.1007/s13555-018-0275-9
  • Yang J, Yang H, Xu A, et al. A review of advancement on influencing factors of acne: an emphasis on environment characteristics. Front Public Health. 2020;8:450. doi:10.3389/fpubh.2020.00450
  • Gollnick HP. From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol. 2015;29(5):1–7.
  • Brzozowska M, Lewiński A. Changes of androgens levels in menopausal women. Prz Menopauzalny. 2020;19:151–154. doi:10.5114/pm.2020.101941
  • Bagatin E, Rocha MADD, Freitas THP, et al. Treatment challenges in adult female acne and future directions. Expert Rev Clin Pharmacol. 2021;14:687–701. doi:10.1080/17512433.2021.1917376
  • Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140:273–282. doi:10.1046/j.1365-2133.1999.02662.x
  • Rapp DA, Brenes GA, Feldman SR, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004;151:183–189. doi:10.1111/j.1365-2133.2004.06078.x
  • Dalgard F, Gieler U, Holm J, et al. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol. 2008;59:746–751. doi:10.1016/j.jaad.2008.07.013
  • Revol O, Milliez N, Gerard D. Psychological impact of acne on 21st-century adolescents: decoding for better care. Br J Dermatol. 2015;172:52–58. doi:10.1111/bjd.13749
  • Oon HH, Lim DZJ, Barbieri JS, et al. A call for action to tackle the increasing global burden and challenges of acne. J Eur Acad Dermatol Venereol. 2023;37:e1430–e1431. doi:10.1111/jdv.19349
  • Tan J, Beissert S, Cook-Bolden F, et al. Evaluation of psychological wellbeing and social impact of combined facial and truncal acne: a multi-national, mixed-methods study. Dermatol Ther. 2022;12:1847–1858. doi:10.1007/s13555-022-00768-0
  • Chang J, Nock MR, Cohen JM, et al. Acne accounts for an almost 2.5-fold higher proportion of dermatology visits among adult females compared to adult males in the United States: a study of the national ambulatory medical care survey from 2002–2016. PLoS One. 2023;18:e0290763.
  • Savage LJ, Layton AM. Treating acne vulgaris: systemic, local and combination therapy. Expert Rev Clin Pharmacol. 2010;3:563–580. doi:10.1586/ecp.10.27
  • Cunliffe WJ, Meynadier J, Alirezai M, et al. Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus Adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol. 2003;49:S218–26. doi:10.1067/S0190-9622(03)01153-8
  • Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med. 2000;9:179–187. doi:10.1001/archfami.9.2.179
  • Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;S0190–9622(23):3389.
  • Branisteanu DE, Toader MP, Porumb EA, et al. Adult female acne: clinical and therapeutic particularities (Review). Exp Ther Med. 2022;23:151. doi:10.3892/etm.2021.11074
  • Khunger N, Mehrotra K. Menopausal acne - challenges and solutions. Int J Women’s Health. 2019;11:555–567. doi:10.2147/IJWH.S174292
  • Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17:184–195. doi:10.1111/j.1396-0296.2004.04019.x
  • Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: prevalence across the life span. J Women’s Health. 2012;21:223–230. doi:10.1089/jwh.2010.2722
  • Rocha MA, Bagatin E. Adult-onset acne: prevalence, impact, and management challenges. Clin Cosmet Invest Dermatol. 2018;11:59–69. doi:10.2147/CCID.S137794
  • Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol. 2001;15:541–545. doi:10.1046/j.1468-3083.2001.00357.x
  • Tanghetti EA, Kawata AK, Daniels SR, et al. Understanding the burden of adult female acne. J Clin Aesthet Dermatol. 2014;7:22–30.
  • Callender VD, Alexis AF, Daniels SR, et al. Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne. J Clin Aesthet Dermatol. 2014;7:19–31.
  • Anaba EL, Oaku IR. The Clinical and Epidemiological Profile of Adult Female Acne Vulgaris in Lagos, Nigeria. West Afr J Med. 2021;38:785–790.
  • Kaleta KP, Bogusławska A, Stefanis AJ, et al. The skin as a mirror of internal disease: comorbidities and epidemiology of acne vulgaris and adult female acne - a cross-sectional study and current state of knowledge. Acta Dermatovenerol Croat. 2020;28:133–140.
  • Kaminsky A, Florez-White M, Bagatin E, et al.; Iberian Latin American Acne Studies Group (GILEA - Grupo Ibero-Latinoamericano de Estudio del Acne). Large prospective study on adult acne in Latin America and the Iberian Peninsula: risk factors, demographics, and clinical characteristics. Int J Dermatol. 58;2019:1277–1282. doi:10.1111/ijd.14441
  • Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009;129:2136–2141. doi:10.1038/jid.2009.47
  • Dreno B, Bagatin E, Blume-Peytavi U, et al. Female type of adult acne: physiological and psychological considerations and management. J Dtsch Dermatol Ges. 2018;16:1185–1194.
  • Antiga E, Verdelli A, Bonciani D, et al. Acne: a new model of immune-mediated chronic inflammatory skin disease. G Ital Dermatol Venereol. 2015;150:247–254.
  • Rocha MA, Costa CS, Bagatin E. Acne vulgaris: an inflammatory disease even before the onset of clinical lesions. Inflamm Allergy Drug Targets. 2014;13:162–167. doi:10.2174/1871528113666140606110024
  • Rothman MS, Wierman ME. How should postmenopausal androgen excess be evaluated? Clin Endocrinol. 2011;75:160–164. doi:10.1111/j.1365-2265.2011.04040.x
  • Davison SL, Bell R, Donath S, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847–3853. doi:10.1210/jc.2005-0212
  • Eliasse Y, Leveque E, Garidou L, et al. IL-17+ mast cell/t helper cell axis in the early stages of acne. Front Immunol. 2021;12:740540. doi:10.3389/fimmu.2021.740540
  • Ramos-e-Silva M, Ramos-e-Silva S, Carneiro S. Acne in women. Br J Dermatol. 2015;172:20–26. doi:10.1111/bjd.13638
  • Zouboulis CC, Chen WC, Thornton MJ, et al. Sexual hormones in human skin. Horm Metab Res. 2007;39:85–95. doi:10.1055/s-2007-961807
  • Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141:333–338. doi:10.1001/archderm.141.3.333
  • Redmond GP. Androgenic disorders of women: diagnostic and therapeutic decision making. Am J Med. 1995;98:S120–S129. doi:10.1016/S0002-9343(99)80070-9
  • Rocha M, Cardozo KHM, Carvalho VM, et al. ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne. Dermatoendocrinol. 2013;9:e1361571.
  • Baxendale PM, Jacobs HS, James VH. Plasma and salivary androstenedione and dihydrotestosterone in women with hyperandrogenism. Clin Endocrinol. 1983;18:447–457. doi:10.1111/j.1365-2265.1983.tb02874.x
  • Abrahin OS, Sousa EC, Santos AM. Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review. Subst Use Misuse. 2014;49:1156–1162. doi:10.3109/10826084.2014.903750
  • Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011;3:41–49. doi:10.4161/derm.3.1.13900
  • Rao A, Douglas SC, Hall JM. Endocrine disrupting chemicals, hormone receptors, and acne vulgaris: a connecting hypothesis. Cells. 2021;10:1439. doi:10.3390/cells10061439
  • Mukherjee P, Sanyal S, Chadha S, et al. The impact of polycystic ovary syndrome (PCOS) on the risk of developing ovarian cancer and thyroid disorders: a comprehensive review. Endocr Metab Immune Disord Drug Targets. 2023;2023:1.
  • Gencoglu S. Relationship between elevated serum decorin levels and acne vulgaris in women with PCOS. Eur Rev Med Pharmacol Sci. 2024;28:457–462. doi:10.26355/eurrev_202401_35044
  • Kazandjieva J, Tsankov N. Drug-induced acne. Clin Dermatol. 2017;35:156–162. doi:10.1016/j.clindermatol.2016.10.007
  • Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474–485. doi:10.1111/bjd.12149
  • Abdelmaksoud A, Vojvodic A, Ayhan E, et al. Depression, isotretinoin, and folic acid: a practical review. Dermatol Ther. 2019;32:e13104.
  • Skroza N, Tolino E, Proietti I, et al. Women and acne: any difference from males? A review of the literature. G Ital Dermatol Venereol. 2016;151:87–92.
  • Cordain L, Lindeberg S, Hurtado M, Hill K, Eaton SB, Brand-Miller J. Acne vulgaris: a disease of Western civilization. Arch Dermatol. 2002;138:1584–1590. doi:10.1001/archderm.138.12.1584
  • Brand-Miller J, Buyken AE. The relationship between glycemic index and health. Nutrients. 2020;12:536. doi:10.3390/nu12020536
  • Meixiong J, Ricco C, Vasavda C, Ho BK. Diet and acne: a systematic review. JAAD Int. 2022;7:95–112. doi:10.1016/j.jdin.2022.02.012
  • Kumari R, Thappa DM. Role of insulin resistance and diet in acne. Indian J Dermatol Venereol Leprol. 2013;79:291–299. doi:10.4103/0378-6323.110753
  • Melnik BC, Schmitz G. Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp Dermatol. 2009;18:833–841. doi:10.1111/j.1600-0625.2009.00924.x
  • Dréno B, Dagnelie MA, Khammari A, et al. The skin microbiome: a new actor in inflammatory acne. Am J Clin Dermatol. 2020;21:18–24. doi:10.1007/s40257-020-00531-1
  • Dréno B, Pécastaings S, Corvec S, et al. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. J Eur Acad Dermatol Venereol. 2018;32 Suppl 2:5–14. doi:10.1111/jdv.15043
  • Dreno B, Dekio I, Baldwin H, et al. Acne microbiome: from phyla to phylotypes. J Eur Acad Dermatol Venereol. 2023;2023:1.
  • Jiang Y, Zhang J, Guo H, et al. Transcriptome comparison of isotretinoin-effective and isotretinoin-ineffective severe acne vulgaris patients. J Cosmet Dermatol. 2021;20:2619–2626. doi:10.1111/jocd.13898
  • Chernyshov PV, Tomas-Aragones L, Manolache L, et al. Which acne treatment has the best influence on health-related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes. J Eur Acad Dermatol Venereol. 2018;32:1410–1419. doi:10.1111/jdv.15048
  • Dumont-Wallon G, Dreno B. [Specificity of acne in women older than 25 years]. Presse Med. 2008;37:585–591. French. doi:10.1016/j.lpm.2007.07.014
  • Artar G, Tas B, Turan G, Uckan HH. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2022;38:1104–1108. doi:10.1080/09513590.2022.2162496
  • Bungau AF, Radu AF, Bungau SG, et al. Oxidative stress and metabolic syndrome in acne vulgaris: pathogenetic connections and potential role of dietary supplements and phytochemicals. Biomed Pharmacother. 2023;164:115003. doi:10.1016/j.biopha.2023.115003
  • Pürnak S, Durdu M, Tekindal MA, et al. The prevalence of malassezia folliculitis in patients with papulopustular/comedonal acne, and their response to antifungal treatment. Skinmed. 2018;16:99–104.
  • Goh CL, Wu Y, Welsh B, et al. Expert consensus on holistic skin care routine: focus on acne, rosacea, atopic dermatitis, and sensitive skin syndrome. J Cosmet Dermatol. 2023;22:45–54. doi:10.1111/jocd.15519
  • Guerra-Tapia A, Serra-Baldrich E, Prieto Cabezas L, González-Guerra E, López-Estebaranz JL. Diagnosis and treatment of sensitive skin syndrome: an algorithm for clinical practice. Actas Dermosifiliogr. 2019;110:800–808. English, Spanish. doi:10.1016/j.ad.2018.10.021
  • Sangha AM. Treatment of post-menopausal acne with tretinoin lotion 0.05% delivers rapid results and concomitant benefits. SAGE Open Med Case Rep. 2020;8:2050313X20929798. doi:10.1177/2050313X20929798
  • Yang Z, Zhang Y, Lazic Mosler E, et al. Topical benzoyl peroxide for acne. Cochrane Database Syst Rev. 2020;3:CD011154.
  • Andriessen A, Lynde CW. Antibiotic resistance: shifting the paradigm in topical acne treatment. J Drugs Dermatol. 2014;13:1358–1364.
  • Capitanio B, Sinagra JL, Bordignon V, et al. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63:782–788. doi:10.1016/j.jaad.2009.11.021
  • Rocha MAD, Guadanhim LRS, Sanudo A, et al. Modulation of toll like receptor-2 on sebaceous gland by the treatment of adult female acne. Dermatoendocrinol. 2017;9:e1361570.
  • George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg. 2008;27:188–196. doi:10.1016/j.sder.2008.06.002
  • Maloney JM, P D, Watson D, et al. Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial. Obstet Gynecol. 2008;112:773–781. doi:10.1097/AOG.0b013e318187e1c5
  • Tyler KH, Zirwas MJ. Contraception and the dermatologist. J Am Acad Dermatol. 2013;68:1022–1029. doi:10.1016/j.jaad.2012.11.018
  • Roberts EE, Nowsheen S, Davis MDP, et al. Treatment of acne with spironolactone: a retrospective review of 395 adult patients at Mayo Clinic, 2007–2017. J Eur Acad Dermatol Venereol. 2020;34:2106–2110. doi:10.1111/jdv.16302
  • Melnik BC. Acne transcriptomics: fundamentals of acne pathogenesis and isotretinoin treatment. Cells. 2023;12:2600. doi:10.3390/cells12222600
  • Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne. Cochrane Database Syst Rev. 2016;9:CD007917. doi:10.1002/14651858.CD007917.pub2
  • Araviiskaia E, Dréno B. The role of topical dermocosmetics in acne vulgaris. J Eur Acad Dermatol Venereol. 2016;30:926–935. doi:10.1111/jdv.13579
  • Dreno B, Araviiskaia E, Berardesca E, et al. The science of dermocosmetics and its role in dermatology. J Eur Acad Dermatol Venereol. 2014;28:1409–1411. doi:10.1111/jdv.12497
  • Bagatin E, Thouvenin MD, Bacquey A, et al. The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: results from a randomized exploratory investigator-blinded comparative study. J Eur Acad Dermatol Venereol. 2023;37:26–30. doi:10.1111/jdv.18795
  • Sorg O, Nocera T, Fontao F, et al. Lipid droplet proteins in acne skin: a sound target for the maintenance of low comedogenic sebum and acne-prone skin health. JID Innov. 2021;1:100057. doi:10.1016/j.xjidi.2021.100057
  • Fontao F, von Engelbrechten M, Seilaz C, et al. Microcomedones in non-lesional acne prone skin New orientations on comedogenesis and its prevention. J Eur Acad Dermatol Venereol. 2020;34:357–364. doi:10.1111/jdv.15926
  • Dall’oglio F, Tedeschi A, Fabbrocini G, et al. Cosmetics for acne: indications and recommendations for an evidence-based approach. G Ital Dermatol Venereol. 2015;150:1–11.
  • Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postepy Dermatol Alergol. 2019;36:392–397. doi:10.5114/ada.2019.87443
  • Joshi M, Hiremath P, John J, et al. Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases. Pharmacol Rep. 2023;75:1096–1114. doi:10.1007/s43440-023-00520-1
  • Chen Y, Han W, Li S, et al. Effects of mesotherapy introduction of compound glycyrrhizin injection on the treatment of moderate to severe acne. J Cosmet Dermatol. 2023;22:1973–1979. doi:10.1111/jocd.15681
  • Dagnelie MA, Montassier E, Khammari A, et al. Inflammatory skin is associated with changes in the skin microbiota composition on the back of severe acne patients. Exp Dermatol. 2019;28:961–967. doi:10.1111/exd.13988
  • Mias C, Thouvenin MD, Gravier E, et al. Change in Cutibacterium acnes phylotype abundance and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol enriched plant cell culture extracts in patients with acne vulgaris. J Eur Acad Dermatol Venereol. 2023;37(2):20–25. doi:10.1111/jdv.18792
  • Rizzo J, Min M, Adnan S, et al. Soy protein containing isoflavones improves facial signs of photoaging and skin hydration in postmenopausal women: results of a prospective randomized double-blind controlled trial. Nutrients. 2023;15:4113. doi:10.3390/nu15194113
  • Ribet V, Nobile V, Rossi AB. In situ antioxidant activity of a dermo-cosmetic product: a randomized controlled clinical study. Exp Dermatol. 2019;28:1219–1226. doi:10.1111/exd.14005
  • Layton AM, Dias da Rocha MA. Real-world case studies showing the effective use of azelaic acid in the treatment, and during the maintenance phase, of adult female acne patients. Clin Cosmet Invest Dermatol. 2023;16:515–527. doi:10.2147/CCID.S396023
  • Rouvrais C, Bacqueville D, Bogdanowicz P, et al. A new dermocosmetic containing retinaldehyde, delta-tocopherol glucoside and glycylglycine oleamide for managing naturally aged skin: results from in vitro to clinical studies. Clin Cosmet Invest Dermatol. 2017;10:35–42. doi:10.2147/CCID.S123575
  • Boyer F, Delsol C, Ribet V, et al. Broad-spectrum sunscreens containing the TriAsorB™ filter: in vitro photoprotection and clinical evaluation of blue light-induced skin pigmentation. J Eur Acad Dermatol Venereol. 2023;37:12–21. doi:10.1111/jdv.19290
  • Kamp E, Ashraf M, Musbahi E, et al. Menopause, skin and common dermatoses. Part 2: skin disorders. Clin Exp Dermatol. 2022;47:2117–2122. doi:10.1111/ced.15308
  • Wines N, Willsteed E. Menopause and the skin. Australas J Dermatol. 2001;42:149–158. doi:10.1046/j.1440-0960.2001.00524.x
  • Norris JF, Cunliff WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651–659. doi:10.1111/j.1365-2133.1988.tb02566.x